Pfenex logo — company profile

Pfenex

Founded 2009 51-200 employees Post Ipo Equity Total: $63.40M Biotechnology, Health Care +1

General Information

Company Name Pfenex
Founded Year 2009
Employees 51-200
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Pfenex moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pfenex

Pfenex is a biotechnology company based in San Diego, California, specializing in recombinant protein expression for various applications. The company's core technology, PfÄ«nex Expression Technology™, utilizes the BSL-1 microorganism Pseudomonas fluorescens and integrates an extensive toolbox of expression components with a robotically enabled high throughput parallel strain screening technology, delivering unmatched speed and success in identifying protein production strains. Founded in 2009, PfÄ«nex focuses on applications such as therapeutic proteins, vaccines, research, reagents, and biosimilars. They received a $39.40MPost-IPO Equity investment on 29 May 2018. Although the last investment's details are not specified, Pfenex's innovative technology and its applications in the biotechnology, health care, and health and wellness industries make it an attractive prospect for potential investors.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 29 May 2018
Series A •••••• 2 •••• •••• 09 Dec 2009

Pfenex Alternatives & Competitors

Pfenex vs

Streamlining protein therapeutics development

14 employees
Pfenex vs
Expression Systems
Expression Systems United States

Committed to providing top-tier products and services for the cell culture and bio-industrial sector...

30 employees
Biotechnology
Pfenex vs

Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates...

7 employees
Biotechnology, Health Care

FAQ About Pfenex

Headquartered in San Diego, California, PfÄ«nex Inc. is a prominent biotechnology company specializing in recombinant protein expression for various applications such as therapeutic proteins, vaccines, research, reagents, and biosimilars. The Company's core technology, PfÄ«nex Expression Technology™...
Pfenex was founded in 2009.
Pfenex operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Pfenex has approximately 51-200 employees.
Pfenex has completed 2 funding rounds, raising a total of $63.40M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Pfenex include Pelican Expression Technology®, Expression Systems, Accelagen, Nex-Tech Wireless, VALIDOGEN GmbH. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pfenex and Pelican Expression Technology® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pfenex and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy